Cargando…

MK2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Mediated by Macrophages and Metabolomic Factors

Cases of pancreatic neuroendocrine tumors (PNETs) are growing in number, and new treatment options are needed in order to improve patient outcomes. The mitogen-activated protein kinase-activated protein kinase 2 (MK2) is a crucial regulator of cytokine/chemokine production. The significance of MK2 e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacenik, Damian, Lebish, Eric J., Beswick, Ellen J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658113/ https://www.ncbi.nlm.nih.gov/pubmed/36362348 http://dx.doi.org/10.3390/ijms232113561

Ejemplares similares

MK2 drives progression of pancreas and colon cancers by suppressing CD8(+) T cell cytotoxic function and is a potential immunotherapy target
por: Jacenik, Damian, et al.
Publicado: (2023)

MK2: an unrecognized regulator of tumor promoting macrophages in colorectal cancer?
por: Castillo, Eliseo F., et al.
Publicado: (2016)

Th2 cells inhibit growth of colon and pancreas cancers by promoting anti-tumorigenic responses from macrophages and eosinophils
por: Jacenik, Damian, et al.
Publicado: (2022)

MK2 Inhibitors as a Potential Crohn’s Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity
por: Lebish, Eric J., et al.
Publicado: (2022)

MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth
por: Phinney, Brandon B., et al.
Publicado: (2018)

G-CSF and G-CSFR Induce a Pro-Tumorigenic Macrophage Phenotype to Promote Colon and Pancreas Tumor Growth
por: Karagiannidis, Ioannis, et al.
Publicado: (2020)

G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets
por: Karagiannidis, Ioannis, et al.
Publicado: (2020)

G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis
por: Jacenik, Damian, et al.
Publicado: (2019)

RABL6A Promotes Pancreatic Neuroendocrine Tumor Angiogenesis and Progression In Vivo
por: Maharjan, Chandra K., et al.
Publicado: (2021)

The MK2 pathway is linked to G-CSF, cytokine production and metastasis in gastric cancer: a novel intercorrelation analysis approach
por: Qeadan, Fares, et al.
Publicado: (2020)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma
por: Berggren, Kiersten L., et al.
Publicado: (2019)

The matricellular protein CYR61 interferes with normal pancreatic islets architecture and promotes pancreatic neuroendocrine tumor progression
por: Huang, Yu-Ting, et al.
Publicado: (2015)

Cooperative and distinct functions of MK2 and MK3 in the regulation of the macrophage transcriptional response to lipopolysaccharide
por: Ehlting, Christian, et al.
Publicado: (2019)

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors
por: Dromain, Clarisse, et al.
Publicado: (2019)

CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors
por: Krug, Sebastian, et al.
Publicado: (2020)

MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors: MEN1 promotes ferroptosis in pancreatic neuroendocrine tumors
por: Ye, Zeng, et al.
Publicado: (2022)

Diagnosis of Pancreatic Neuroendocrine Tumors
por: Lee, Dong Wook, et al.
Publicado: (2017)

CD47 expression and CD163(+) macrophages correlated with prognosis of pancreatic neuroendocrine tumor
por: Imam, Rami, et al.
Publicado: (2021)

Protease-Activated Receptors – Key Regulators of Inflammatory Bowel Diseases Progression
por: Jacenik, Damian, et al.
Publicado: (2021)

Pancreatic paraganglioma mimicking pancreatic neuroendocrine tumor
por: Abbasi, Arezou, et al.
Publicado: (2020)

Sarcoidosis mimicking metastatic progression of pancreatic neuroendocrine tumor: A case report
por: Lolli, Ivan, et al.
Publicado: (2017)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Treatment Options for Pancreatic Neuroendocrine Tumors
por: Akirov, Amit, et al.
Publicado: (2019)

Surgical Management of Pancreatic Neuroendocrine Tumors
por: Sulciner, Megan L., et al.
Publicado: (2023)

Chronic Macrophage Migration Inhibitory Factor Exposure Induces Mesenchymal Epithelial Transition and Promotes Gastric and Colon Cancers
por: Morris, Katherine T., et al.
Publicado: (2014)

Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment
por: Zhang, Ming-Yi, et al.
Publicado: (2020)

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors
por: Simon, Tincy, et al.
Publicado: (2022)

Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition
por: Xiong, Cheng, et al.
Publicado: (2021)

Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
por: Lin, Liang-Yu, et al.
Publicado: (2017)

Effects of Ketamine, S-Ketamine and MK 801 on Integrin Beta-3-mediated Cell Migration in Pancreatic Carcinoma
por: Malsy, Manuela, et al.
Publicado: (2022)

Microforceps-Assisted Diagnosis of Cystic Pancreatic Neuroendocrine Tumor
por: Trikudanathan, Guru, et al.
Publicado: (2019)

Diet as a Source of Acrolein: Molecular Basis of Aldehyde Biological Activity in Diabetes and Digestive System Diseases
por: Hikisz, Pawel, et al.
Publicado: (2023)

The Tobacco Smoke Component, Acrolein, as a Major Culprit in Lung Diseases and Respiratory Cancers: Molecular Mechanisms of Acrolein Cytotoxic Activity
por: Hikisz, Pawel, et al.
Publicado: (2023)

Pancreatic Collision Tumor of Ductal Adenocarcinoma and Neuroendocrine Tumor
por: Wang, Yuchen, et al.
Publicado: (2018)

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases
por: Imperiale, Alessio, et al.
Publicado: (2019)

Pancreatic neuroendocrine tumors: biology, diagnosis, and treatment
por: Ro, Cynthia, et al.
Publicado: (2013)

Pancreatic Neuroendocrine Tumor with Atypical Radiologic Presentation
por: Singh, Ramandeep, et al.
Publicado: (2015)

Recent developments in imaging of pancreatic neuroendocrine tumors
por: Kartalis, Nikolaos, et al.
Publicado: (2015)

Irreversible electroporation for the treatment of pancreatic neuroendocrine tumors
por: Papamichail, Michail, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dmh5f9pcvif9j2f31o0jeu2n1e